The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard for addressing health inequities.
Morgan Conn, Ph.D., seasoned biotech executive with expertise in financing, business development, and corporate strategy, appointed as Chief Financial Officer - - Chad Cowan, Ph.D., cell therapy ...
Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune checkpoint inhibitor therapy, according to a preclinical study. The findings ...
The Philippine Society for Blood and Bone Marrow Transplantation is holding its eighth post-graduate course this weekend with the theme: Transplant 360°: Stakeholders’ Perspectives on HSCT at the ...